
Sign up to save your podcasts
Or


Two FDA-approved MASH therapies are changing care. Learn how resmetirom and semaglutide work—and what's next in the pipeline.
Credit available for this activity expires: 6/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/updates-metabolic-dysfunction-associated-steatohepatitis-2026a1000jmw?ecd=bdc_podcast_libsyn_mscpedu
Decode low back pain. Master the latest clinical guidelines and NSAID safety data to optimize your patient treatment strategies.
Credit available for this activity expires: 6/18/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/unlocking-enigma-low-back-pain-zeroing-effective-treatment-2026a1000jte?ecd=bdc_podcast_libsyn_mscpedu
Dr Naim Alkhouri reviews treatment strategies for metabolic dysfunction-associated steatohepatitis (MASH) with significant fibrosis.
Credit available for this activity expires: 06/11/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/managing-mash-modern-era-episode-2-managing-mash-guide-gi-2026a1000ilz?ecd=bdc_podcast_libsyn_mscpedu
Optimize CLL and MCL care: experts discuss the latest data on sequencing and personalizing therapies across all lines of treatment to improve outcomes.
Credit available for this activity expires: 06/12/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/chronic-lymphocytic-leukemia-data-driven-updates-first-line-2026a1000imb?ecd=bdc_podcast_libsyn_mscpedu
Not all patients are the same, so why should their prevention strategies be?
Credit available for this activity expires: 6/11/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/episode-6-personalizing-cardiovascular-prevention-methods-2026a1000eep?ecd=bdc_podcast_libsyn_mscpedu
Evaluate case-based management strategies for chronic lymphocytic leukemia (CLL) from first line to cellular therapy.
Credit available for this activity expires: 6/8/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-next-steps-cll-collaborative-dialogue-2026a1000i1d?ecd=bdc_podcast_libsyn_mscpedu
Did your patient stop treatment because they found peace, or because they lost hope?
Credit available for this activity expires: 06/09/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-psychosocial-impact-dermatologic-disease-patient-2026a1000gts?ecd=bdc_podcast_libsyn_mscpedu
Stay up to date with practical strategies in the management of patients with acromegaly.
Credit available for this activity expires: 06/03/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/advancing-care-acromegaly-expert-insights-optimizing-current-2026a1000i1h?ecd=bdc_podcast_libsyn_mscpedu
Do you know when to augment therapy for your patients with major depressive disorder (MDD) who are experiencing residual symptoms?
Credit available for this activity expires: 06/04/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-voice-mdd-why-and-when-augment-therapy-2026a1000hv4?ecd=bdc_podcast_libsyn_mscpedu
Do you know how to manage patients with GERD who are not responding adequately to PPI therapy?
Credit available for this activity expires: 6/2/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/managing-erosive-esophagitis-when-ppis-are-insufficient-2026a1000hbt?ecd=bdc_podcast_libsyn_mscpedu
From the publisher's feed

136 Listeners

697 Listeners

496 Listeners

162 Listeners

103 Listeners

892 Listeners

13 Listeners

16 Listeners

290 Listeners

265 Listeners

3,343 Listeners

1,157 Listeners

195 Listeners

93 Listeners

520 Listeners

372 Listeners

170 Listeners

60 Listeners

8 Listeners

431 Listeners